Hi, what are you looking for?
It will expand its collaboration with United Therapeutics to include the 3D bio printing of Human Kidneys for Transplant.
Israel’s CollPlant, which develops and manufactures human collagen-based medical products, has treated the first patient in its VergenixFG clinical trial in Israel. The VergenixFG...
– – The company was awarded a patent on its method of producing human collagen in plants. – – Shares in CollPlant Holdings...
– The company also raised NIS 63 million in future options and hopes to bring two products to the European market by 2015. –...
– The Chinese company will invest $4 million in CollPlant in exchange for an allotment of shares and the commercialization of its products in...
For the first time, Technion scientists succeeded in constructing a network of major and small blood arteries, crucial for giving blood to implanted tissue
Israeli High-Tech Industry Updates Israel awards 10 institutional investment firms safety net for tech investments Institutional Investors will be entitled to receive back...
Israel may be a tiny country, but it's impact worldwide has been phenomenal. We take a look back at some of the country's biggest...
CollPlant which focuses on 3D bioprinting of tissues and organs signed an agreement with United Therapeutics Corporation for 3D bioprinted lung transplants.
Based on electromagnetic properties of human sweat ducts, Neteera’s technology can help catch biometric identification of stress, fatigue, pain, alcohol influence, drug abuse detection,...